SCHEMBL1503555

SCHEMBL1503555

CCN[C@@H](CNC(=O)OC(C)(C)C)C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
CTSS P25774 4/20 0.39
CTSK P43235 4/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 3/20 0.39
CA14 Q9ULX7 1/20 0.39
CAPN1 P07384 1/20 0.39
SERPINE1 P05121 1/20 0.39
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2894524 0.86 CTSS (0.43) SYKMEN1GAAKMT2ACTSS
SCHEMBL2896274 0.86 CTSS (0.43) SYKMEN1GAAKMT2ACTSS
SCHEMBL13295689 0.86 CTSS (0.43) SYKMEN1GAAKMT2ACTSS
SCHEMBL10475828 0.85 MEN1 (0.49) SYKMEN1GAAKMT2ACTSS
SCHEMBL10475827 0.85 MEN1 (0.49) SYKMEN1GAAKMT2ACTSS
SCHEMBL14110740 0.85 MEN1 (0.44) SYKMEN1GAAKMT2ACTSS
SCHEMBL6872152 0.83 MEN1 (0.42) SYKMEN1GAAKMT2ACTSS
SCHEMBL20479736 0.83 CTSK (0.49) SYKMEN1GAAKMT2ACTSS
SCHEMBL20479738 0.83 CTSK (0.49) SYKMEN1GAAKMT2ACTSS
SCHEMBL10328422 0.83 MEN1 (0.42) SYKMEN1GAAKMT2ACTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033010-A1 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed